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The endosomal sorting complexes required for
transport (ESCRTs) facilitate endosomal sorting of
ubiquitinated cargo, MVB biogenesis, late stages of
cytokinesis, and retroviral budding. Here we show
that ubiquitin associated protein 1 (UBAP1), a subunit
of human ESCRT-I, coassembles in a stable 1:1:1:1
complex with Vps23/TSG101, VPS28, and VPS37.
The X-ray crystal structure of the C-terminal region
of UBAP1 reveals a domain that we describe as a
solenoid of overlapping UBAs (SOUBA). NMR anal-
ysis shows that each of the three rigidly arranged
overlapping UBAs making up the SOUBA interact
with ubiquitin. We demonstrate that UBAP1-contain-
ing ESCRT-I is essential for degradation of anti-
viral cell-surface proteins, such as tetherin (BST-
2/CD317), by viral countermeasures, namely, the
HIV-1 accessory protein Vpu and the Kaposi
sarcoma-associated herpesvirus (KSHV) ubiquitin
ligase K5.
INTRODUCTION
The endosomal sorting complex required for transport (ESCRT)
machinery facilitates the lysosomal degradation of ubiquitinated
cell surface receptors (Hurley and Stenmark, 2011; Katzmann
et al., 2001). ESCRT proteins are conserved from yeast to hu-
mans and form four multiprotein complexes termed ESCRT-0,
ESCRT-I, ESCRT-II, and ESCRT-III (Henne et al., 2011; Williams
and Urbe´, 2007). ESCRT-0, -I, and -II capture ubiquitinated
membrane proteins for sorting into intraluminal vesicles (ILV)
within endosomes to form structures known as multivesicular
endosomes or multivesicular bodies (MVB) (Shields and Piper,
2011).
The ESCRT machinery is also essential for resolution of the
midbody during cytokinetic abscission (Carlton and Martin-
Serrano, 2007; Morita et al., 2007b), a process that is topologi-
cally equivalent to MVB formation. The ability of the ESCRTs to
mediate scission of a thin membranous stalk is also exploited414 Structure 20, 414–428, March 7, 2012 ª2012 Elsevier Ltd All righby several enveloped viruses such as HIV-1 to facilitate their
release from infected cells (Baumga¨rtel et al., 2011; Jouvenet
et al., 2011; Martin-Serrano and Neil, 2011; Morita and Sund-
quist, 2004; Morita et al., 2011; Weissenhorn and Go¨ttlinger,
2011). In particular, HIV-1 encodes a PTAP motif that recruits
ESCRT-I to the sites of viral budding through a direct interaction
with theUEV domain in TSG101 (Pornillos et al., 2002). Additional
roles of ESCRT-I in viral pathogenesis include its cooption by
gamma-herpesviruses (Nathan and Lehner, 2009) and HIV for
the degradation of various antiviral cell-surface proteins such
as tetherin (BST-2/CD317) (reviewed in Martin-Serrano and
Neil, 2011). Tetherin is an antiviral type II membrane glycoprotein
that is induced by interferons and physically inhibits enveloped
virus particle release from infected cells by cross-linking nascent
virions to the plasma membrane. Specifically, the HIV-1 acces-
sory protein Vpu counteracts tetherin activity and promotes its
ESCRT-dependent degradation via the lysosomal pathway
(Janvier et al., 2011). Kaposi sarcoma-associated herpesvirus
(KSHV) encodes K5, a membrane-bound E3 ubiquitin ligase
that results in a similar effect (Bartee et al., 2006; Mansouri
et al., 2009; Pardieu et al., 2010).
ESCRT-I is formed by four subunits, Vps23/TSG101, Vps28,
Vps37, and Mvb12. The yeast ESCRT-I heterotetramer contains
a fan-shaped headpiece formed by a heterotrimeric core con-
sisting of the C-terminal ‘‘steadiness box’’ of Vps23p, the
N-terminal half of Vps28p, and the C-terminal half of Vps37p
(Kostelansky et al., 2006; Teo et al., 2006). This headpiece
connects to an extended stalk formed by Mvb12p, Vps23p,
and Vps37p. The stalk is essential for yeast ESCRT-I function
in cargo sorting. The C-terminal domain of Vps28p is flexibly
tethered to the headpiece and binds ESCRT-II, whereas the flex-
ibly attached UEV domain of Vps23p binds to ESCRT-0 (Koste-
lansky et al., 2007). This structural organization is thought to be
conserved in mammalian ESCRT-I and was used as the basis to
identify, to our knowledge, novel subunits of the complex.
However, in mammalian cells, ESCRT-I has evolved a much
greater diversity of subunits than in yeast, including multiple
isoforms of VPS37 and MVB12 (Bache et al., 2004; Eastman
et al., 2005; Morita et al., 2007a; Stuchell et al., 2004).
Using our sensitive generalized profile method for sequence
comparison (Bucher et al., 1996), we identified a highly signif-
icant relationship between a profile constructed from different
vertebrate and invertebrate MVB12 sequences and the proteints reserved
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between UBAP1 and MVB12 that was named UBAP1-MVB12-
associated (UMA) domain (de Souza and Aravind, 2010) (Fig-
ure 1A). The UMA domain corresponds to a region that was
previously described as the ESCRT-I binding box (EBB)
(Morita et al., 2007a) and is located in the C terminus of
MVB12 and in the N terminus of UBAP1. UBAP1 is expressed
in a wide range of tissues and is embryonic lethal when
deleted in mice (http://www.sanger.ac.uk/mouseportal/
search?query=ubap1). It is part of a locus that experiences
a loss of heterozygosity in human nasopharyngeal cancers
(Qian et al., 2001). Recently, UBAP1 was identified as a risk
factor in familial frontotemporal lobar dementia (FTLD) (Rollin-
son et al., 2009).
In contrast to the MVB12A and MVB12B subunits, which have
an N-terminal extension consisting of a MABP b-prism domain
(de Souza and Aravind, 2010), UBAP1 has a greatly expanded
C-terminal region, which contains three putative ubiquitin asso-
ciated (UBA) domains. A number of ubiquitin-binding domains
(UBDs) have been described, including CUE, UIM, NZF, UEV,
GLUE, GGA, GAT, and UBA (Dikic et al., 2009). The UBA domain
is the most frequently occurring UBD, with 84 sequences in the
human genome according to Pfam (http://pfam.sanger.ac.uk).
UBAs have about 45 residues folded into a compact three-helix
bundle with a right-handed twist. UBA domains have a
conserved signature motif M/L-G-Y/F in the a1/a2 loop that
forms part of the interaction with ubiquitin, and there is a
conserved di-leucine motif at the end of helix a3 (Hofmann and
Bucher, 1996; Mueller and Feigon, 2002; Ohno et al., 2005).
UBAs have been grouped in four classes according to their
preference for polyubiquitin linkages: K48-linked polyubiquitin,
K63-linked polyubiquitin, promiscuous recognition of multiple
polyubiquitin linkages, and no ubiquitin recognition (Raasi
et al., 2005). UBA domains typically also bind monoubiquitin,
but generally with much lower affinity.
UBAs have important roles in many different contexts,
including diverse degradative pathways. Several UBA-contain-
ing proteins, such as Rad23 and Dsk2, function as adaptors
for proteasome degradation (Clague and Urbe´, 2010). Degrada-
tion of polyubiquitinated protein aggregates depends on their
recruitment to autophagosomes by the UBA domain of p62
(Pohl, 2009). The ESCRT complexes involved in MVB sorting in
yeast contain a number of UBDs, including UIMs, VHS, NZF,
andUEV domains (Shields and Piper, 2011). However, disruption
of the individual UBDs in the ESCRT complexes does not
block the MVB pathway and only a quadruple mutant that is
completely defective for ubiquitin binding shows severe sorting
defects (Shields et al., 2009). Intriguingly, UBA domains are
absent from the MVB pathway in yeast.
We report here the structure of the C-terminal region of UBAP1
that folds as a solenoid of overlapping UBAs (SOUBA) domain.
NMR data show that each of the three UBA domains composing
SOUBA binds monoubiquitin. This is consistent with the specific
role of UBAP1 in endosomal sorting of ubiquitinated membrane
cargo as shown recently for EGFR by Woodman and colleagues
(Stefani et al., 2011). We show that UBAP1 is required for
ubiquitin-dependent degradation of the antiviral protein tetherin
triggered by the viral countermeasures HIV-I protein Vpu and
KSHV viral protein K5.Structure 20,RESULTS
Composition and Stoichiometry of ESCRT-I Complexes
Containing UBAP1
Recombinant full-length human UBAP1, when coexpressed in
Escherichia coli together with ESCRT-I subunits VPS28,
TSG101, and VPS37A, forms a stable complex with 1:1:1:1
stoichiometry of the four subunits (Figure 1B; Figure S1 available
online). The cores of VPS37A, VPS37B, VPS37C, or VPS37D all
give rise to stable recombinant ESCRT-I complexes with UBAP1
in E. coli (Figure S1A). Endogenous UBAP1 from HEK293 cell
lysate eluted close to the 440 kDa marker in a complex contain-
ing TSG101 (Figure S1B). In addition, endogenous UBAP1 was
efficiently copurified with TSG101 and VPS37A from a cell line
stably expressing TSG101 with a One-Strep tag (OSHA-
TSG101) (Figure 1C). The OSHA-TSG101 fusion is expressed
at endogenous levels in these cells (McDonald and Martin-
Serrano, 2008), allowing affinity purification of TSG101-binding
proteins under physiological conditions. Similarly, endogenous
TSG101 also bound UBAP1 and VPS28 when these proteins
were overexpressed in 293T cells as GST fusions and purified
with glutathione beads (Figure S1C). As observed for other
ESCRT-I subunits, UBAP1 functionally recruits the ESCRT
machinery in a trans-complementation assay based on the
rescue of a L-domain defective HIV-1 by direct fusion of
a component of the ESCRTmachinery to a defective Gag protein
(Martin-Serrano et al., 2001). Expression of UBAP1 fused to the
C terminus of the complementing Gag protein restored infec-
tious virus production (Figures S1E–S1H).
Deletion analysis using recombinant proteins showed that the
N-terminal fragment of UBAP1 comprising residues 1 to 68 is
sufficient to form a stable complex with TSG101, VPS28, and
VPS37A (Figure 1D). This N-terminal construct corresponds to
the UMA domain (Figure 1A). Overexpression of UMA domain
constructs YFP-UBAP11-68 and YFP-UBAP11-92 in 293T cells
transfected with HIV-1 proviral DNA has a dominant negative
effect, resulting in approximately 5-fold inhibition of HIV-1 infec-
tious virus release (Figure S1D). This suggests that overexpres-
sion of the UBAP1’s ESCRT-I binding region disrupts the
stoichiometric composition or proper localization of endogenous
ESCRT-I, thus inhibiting HIV-1 budding, as previously shown for
TSG101 (Martin-Serrano et al., 2003).
To identify UMA residues necessary for interaction with other
ESCRT-I subunits, we tested point mutants in several conserved
residues of this domain for their ability to form ESCRT-I
complexes (UMA mutants M1 to M4 in Figure 1A). Given that
yeast Mvb12 is involved in direct contact with Vps37 (Kostelan-
sky et al., 2007), we tested the ability of UMA mutants to
assemble into ESCRT-I complexes containing either VPS37A
or VPS37B. Cells were transfected with plasmids expressing
GST-TSG101, Myc-VPS28, HA-VPS37A/B, and HA-UBAP1,
followed by purification using glutathione-coated beads and
immunodetection of tagged ESCRT-I subunits. Alanine substitu-
tions L17D18D19/AAA and V20P21F22/AAA (mutants M1 and M2)
led to a complete block in ESCRT-I binding (Figure 1E, lanes
4 to 7), whereas F28A (mutant M3) did not (Figure 1E, lanes 8
and 9). Interestingly, mutation of the conserved Glu-59 (E59A,
mutant M4) resulted in loss of binding to ESCRT-I when
HA-VPS37B was cotransfected but not when HA-VPS37A was414–428, March 7, 2012 ª2012 Elsevier Ltd All rights reserved 415
Figure 1. UBAP1 Forms a Stable Heterotetrameric Complex with ESCRT-I Subunits TSG101, VPS28, and VPS37 In Vitro and In Vivo
(A) Schematic representation of the ESCRT-I heterotetramer illustrating the putative UBAP1 arrangement relative to other ESCRT-I subunits. The top sequence
alignment shows the UMA domain, also present in the C-terminal part of MVB12A and MVB12B. The bottom part shows a detailed view of the conserved
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UBAP1 Is Required for Tetherin Degradationpresent in the protein complex (Figure 1E, lanes 10 and 11), sug-
gesting that the VPS37 subunits interact directly with UBAP1.
These results were confirmed with the HIV-1 trans-complemen-
tation assay, showing that fusing UBAP1 constructs bearing the
mutations M1, M2, or M4 to Gag did not restore release of
a budding deficient HIV-1 as compared to wild-type UBAP1 or
M3, indicating that these residues are needed for UBAP1’s inter-
action with ESCRT-I components (Figure S1H).
UBAP1 Functions in MVB Sorting of the Antiviral
Protein Tetherin
Given the role of the ESCRT machinery in sorting ubiquitinated
membrane proteins, we tested the function of UBAP1 in this
process. We took advantage of the ability of several viruses to
reduce cell surface expression of the antiviral protein tetherin
in infected cells via the ESCRTmachinery. The first experimental
approach is based on HIV-1’s Vpu capacity to mediate tetherin
degradation. Thus, 293T cells stably expressing human tetherin
(293T/tetherin) were treated with UBAP1-specific siRNA or a
nontargeting control and subsequently were infected with either
HIV-1 (HIV-1 wt) or Vpu-defective HIV-1 (HIV-1 delVpu) as
a control. Tetherin was then immunoprecipitated, deglycosy-
lated, and visualized by western blot. As expected, cells infected
with HIV-1 wild-type have greatly reduced levels of tetherin
(Figure 2A). However, this tetherin degradation was prevented
in UBAP1-depleted cells infected with HIV-1 wild-type virus,
and a large amount of tetherin was detected in these cells.
This tetherin in UBAP1-depleted, HIV-1-infected cells is highly
ubiquitinated (compare the first and second lanes in Figure 2B),
suggesting that the ubiquitin-dependent sorting by the MVB
pathway is inhibited in the absence of UBAP1. Tetherin levels
in cells infected with a Vpu-defective HIV were high, similar to
uninfected cells. Despite the restoration of tetherin levels in the
UBAP1-depleted cells infected with wild-type HIV-1, viral
release was not affected (Figure 2C). As expected, Vpu-defec-
tive virus release was approximately 100-fold less efficient
than the wild-type virus in tetherin-expressing cells (Neil et al.,
2008), and UBAP1 depletion did not affect this. These results
show that, although Vpu induces targeting of tetherin for
UBAP1-dependent ESCRT-mediated degradation, tetherin’s
ultimate destruction is not mandatory for Vpu to counteract its
antiviral activity. Rather it suggests that Vpu interactions with
tetherin (prior to UBAP1/ESCRT-I recruitment) inactivate the
protein by committing it to an endosomal pathway from whichsequence corresponding to the SOUBA domain in the C-terminal region of UBAP
(M/L)-G-(Y/F) motif for the three successive UBA domains are identified by blue, p
from the structure are shown above the alignment.
(B) Gel filtration of recombinant ESCRT-I containing UBAP1-His6 on a HiLoad
SDS-PAGE gel of the peak fraction containing the tetrameric ESCRT-I complex
(C) ESCRT-I protein complexes from cells stably expressing One-Strep tagged
visualized by western blot. One percent of the starting cell lysate and 10% of the
anti-TSG101, anti-VPS37A, and anti-UBAP1 antibodies. As a control for the spec
(OSHA) is also shown.
(D) Deletion analysis to determine the minimal ESCRT-I binding region on UBA
(1–92, lane 3; 1–77, lane 2; or 1–68, lane 1), with a His6 tag at the C terminus we
and purified by affinity chromatography and gel filtration. A Coomassie-stained S
(E) Coprecipitation studies to map the interaction of UBAP1 with ESCRT-I. 293T
HA-VPS37A/B, and HA-UBAP1 wild-type (WT) or mutant (M1 to M4), followed b
lysate and 10% of the volume eluted from the beads (pull-down) were analyzed
Structure 20,it cannot escape back to the cell surface to inhibit virus release.
Furthermore, the ability of tetherin to restrict HIV-1 delVpu
release equivalently in UBAP1-depleted cells suggests that this
knockdown has no significant effect on tetherin trafficking to
the plasma membrane.
The second approach to determine UBAP1’s function in endo-
somal sorting involved K5, a KSHV-encoded ubiquitin ligase that
reduces cell surface expression of tetherin (Mansouri et al., 2009;
Pardieu et al., 2010). We followed a knockdown approach in
HT1080 cells stably expressing an HA-tetherin construct in addi-
tion to K5 (HT1080/HA-THN/K5). A quantitative western blot
analysis was used to measure the total levels of HA-tetherin
present in these cells. As expected, cells expressing K5 ubiquitin
ligase had much lower levels of HA-tetherin (Figure 3A, lower
panel). Transfection of siRNAs targeting UBAP1 prevented
K5-mediated tetherin degradation, and tetherin protein levels
were significantly rescued (lower panel in Figure 3A). Impor-
tantly, no changes in HA-tetherin were found when the same
siRNAs were transfected into cells lacking K5. As a control,
depletion of TSG101 also resulted in impairment of HA-tetherin
degradation by K5 (Figure 3A). In agreement with the Vpu data,
high-molecular-weight forms of tetherin, suggesting ubiquiti-
nated species of the protein, were accumulated both in UBAP1
and TSG101 depleted cells (Figure 3A). Consistent with inhibition
of endosomal sorting in UBAP1-depleted cells, HA-tetherin
accumulated in intracellular punctae that display partial colocal-
ization with the late endosomal marker CD63 and with ubiquitin
(Figure 3B), a phenotype that is also observed in TSG101-
depleted cells. Overall, these results show that UBAP1 is re-
quired for MVB sorting of an ubiquitinated cargo protein, namely
tetherin.
UBAP1 Is Not Required for HIV-1 Budding or Cytokinesis
We also tested the role of UBAP1 in two other ESCRT-facilitated
processes, namely HIV-1 budding and the resolution of the mid-
body during cytokinesis. Surprisingly, depletion of UBAP1 (more
than 92%decrease in protein level) with two different siRNAs did
not alter significantly HIV-1 budding, whereas TSG101 depletion
inhibited infectious HIV-1 production as expected (Figure 4A). A
similarly negative result was obtained in cytokinesis: although
depletion of hIST1, an ESCRT-related protein essential for cyto-
kinesis (Agromayor et al., 2009; Bajorek et al., 2009), resulted in
cytokinesis failure and accumulation of multinucleated cells,
UBAP1 depletion did not (Figure 4B). The lack of an effect of1 from various species. Hallmark UBA residues homologous to the conserved
ink, and orange triangles, respectively. Positions of the seven a helicesmapped
16/60 Superdex 200 column. The inset shows a Coomassie blue-stained
including UBAP1. See also Table S1 and Figure S1.
TSG101 (OSHA-TSG101) were affinity purified on a Strep-Tactin matrix and
volume eluted from the matrix (pull-down) were analyzed by western blot with
ificity of the binding, purification from cells stably expressing an empty vector
P1. Recombinant UBAP1, either full length (lane 4) or N-terminal fragments
re coexpressed with TSG101/VPS28/VPS37A ESCRT-I components in E. coli
DS-PAGE of the purified complexes is shown.
Cells were transfected with plasmids expressing GST-TSG101, Myc-VPS28,
y purification using glutathione-coated beads. One percent of the starting cell
by western blot with anti-HA antibody. See also Figure S1 and Table S1.
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Figure 2. UBAP1 Is Essential for Degradation of Tetherin Triggered by Viral Countermeasures
(A) Tetherin was immunoprecipitated from 293T cells stably expressing tetherin. The cells were uninfected (uninf), infected with HIV-1 (HIV-1 wt), or Vpu-defective
HIV-1 (HIV-1 delVpu) and were treated with irrelevant control siRNA (Cont) or with siRNAs against UBAP1 (UBAP1Q3 and UBAP1Q4). Western blots show the
immunoprecipitated tetherin (upper panel), siRNA-mediated silencing of the endogenous UBAP1 (middle panel), and the HSP90 as a protein loading control
(lower panel).
(B) Tetherin was immunoprecipitated from cells infected with HIV-1 (HIV-1 wt) and transfected with a plasmid expressing HA-tagged Ubiquitin and either control
(cont) or UBAP1 specific siRNA (UBAP1 Q3). Tetherin ubiquitination was visualized with anti-HA antibody (top panel, THN-Ubn). As a control, the same analysis
was performed in cells infected with a Vpu-defective HIV-1 (HIV-1 delVpu) and treated with an irrelevant siRNA (Cont). Bottom panels show immunoprecipitated
tetherin, UBAP1 depletion and tubulin as a loading control.
(C) Infectious HIV-1 virion production was measured by inoculation of TZM-bl indicator cells and is expressed as relative luminescence units (R.L.U.). Error bars
indicate the standard deviation from the mean of three independent experiments. See also Table S2.
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UBAP1 Is Required for Tetherin DegradationUBAP1 depletion on cytokinesis is consistent with results
recently reported (Stefani et al., 2011). One possible explanation
for this lack of phenotype is that the residual amount of UBAP1
protein in siRNA treated cells might be sufficient to support
ESCRT-I function but the fact that similar levels of depletion in
control experiments result in endosomal defects (shown above)
argues against this possibility.
UBAP1 Is a Ubiquitin-Binding ESCRT-I Subunit
The specific requirement of UBAP1 in endosomal sorting and
the accumulation of ubiquitinated cargo after UBAP1 depletion
from the cell suggested that UBAP1 might promote recognition
of ubiquitinated cargo by ESCRT-I. We checked ubiquitin
binding in solution in a label-free setup, using isothermal titra-
tion calorimetry (ITC). Using a recombinant fragment of
UBAP1 consisting of the proposed UBA-containing region alone
(residues 389 to 502), the Kd for the interaction with ubiquitin
was about 70 mM (Figure 5A). This is on the higher-affinity end
of the 20–1300 mM range commonly observed for UBA domains
binding to monoubiquitin. Furthermore, this is a relatively high418 Structure 20, 414–428, March 7, 2012 ª2012 Elsevier Ltd All righaffinity among UBDs in the ESCRT pathway. We also measured
binding of monoubiquitin to full-length UBAP1 in an ESCRT-I
complex containing a TSG101 subunit with the N-terminal ubiq-
uitin-binding UEV domain deleted in order to avoid ubiquitin
binding by TSG101. The apparent Kd for the interaction
between ESCRT-I/UBAP1 and monoubiquitin is about 140 mM
(Figure 5B). Because many UBAs bind K48-linked diubiquitin
with significantly higher affinity than monoubiquitin (typical
Kds for K48-linked diubiquitin are 1–10 mM) and some UBAs
bind K63-linked diubiquitin, we performed ITC experiments for
label-free K48-linked or K63-linked diubiquitin binding to the
SOUBA. We find that these diubiquitins bind the isolated
SOUBA with an affinity comparable to that observed with mono-
ubiquitin (Figure 5).
Structural Analysis of the C-Terminal UBA-Containing
Region of UBAP1
UBAP1 has two copies of an M/L-G-F/Y motif, which have
recently been shown by mutagenesis to be important for
endosomal sorting (Stefani et al., 2011). To gain insight intots reserved
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UBAP1 Is Required for Tetherin Degradationthe organization and function of this region, we have deter-
mined its crystal structure and characterized its binding to
ubiquitin in solution by NMR. Two constructs covering the
UBAP1 C terminus, residues 381–502 and 389–502, produced
ample protein but did not crystallize. Therefore, we used the
surface entropy reduction approach (Derewenda, 2011) guided
by the SERp Server (Goldschmidt et al., 2007) (http://services.
mbi.ucla.edu/SER) to generate several mutants in which clus-
ters of charged surface residues were mutated to alanine.
One of these mutants, with 415-KKGE-418 mutated to AAGA,
readily crystallized. The 1.65 A˚ resolution crystal structure of
the UBA-containing C-terminal region from UBAP1 has two
molecules in the asymmetric unit that are linked to each other
through a disulfide bond. However, multiangle laser light scat-
tering indicates that the molecule is a monomer in solution
(data not shown). It appears that the disulfide-linked dimer is
formed as the protein oxidizes during the crystallization
process. The structure shows a single domain consisting of
seven a helices arranged as a right-handed solenoid that
contains three overlapping UBAs (UBA1, UBA2, and UBA3)
(Figure 6A). We will refer to this, to our knowledge, novel
domain as a solenoid of overlapping UBAs (SOUBA). The rela-
tionship of the SOUBA fold to conventional UBAs can best be
described by regarding the third helix of one UBAs being also
the first helix of the next UBA (Figures 6A and 6B). There are
several examples of proteins that have multiple UBAs con-
nected by linkers of low complexity that are probably structur-
ally disordered. However, this is the first example of a rigid
array of overlapping UBAs. The solenoid arrangement of the
three UBAs forms a convex surface containing helices one
and three from each UBA. The opposite face forms a concave
surface built from the second helix from each UBA. The angles
between helices in each of the UBAs are within the range
observed for other UBAs. Consequently, each of the compo-
nent UBAs align well with UBA structures from other proteins
(Figure 6C).
Interaction of the SOUBA with Monoubiquitin
Chemical shift perturbations (CSPs) of 15N-labeled ubiquitin on
the addition of unlabeled SOUBA show shifts of residues in
a hydrophobic patch on the surface of the ubiquitin that
includes Ile44 and Val70 (Figures 7A–7C). Extensive structural
analysis of diverse UBAs interacting with monoubiquitin has
shown that the interaction surface on UBAs commonly includes
two hydrophobic UBA patches, at the end of helix a1/loop 1
and on helix a3 (Zhang et al., 2008). Binding to K48-linked poly-
ubiquitin typically includes an additional patch on a2 and the
other side of a3. CSPs of the 15N-labeled SOUBA domain on
addition of three molar equivalents of unlabeled monoubiquitin
indicate that each of the three overlapping UBAs is influenced
by ubiquitin binding (Figures 7D–7F). The residues showing
the greatest perturbation lie along the convex face of the
SOUBA domain and cover an extended hydrophobic surface
(Figure 7F). The signature M/L-G-F/Y motifs are located along
one side of the SOUBA domain, and CSPs suggest that these
residues are involved in binding ubiquitin. This is consistent
with the ubiquitin binding that has been reported for UBAs
from other proteins (Long et al., 2008; Ohno et al., 2005; Vara-
dan et al., 2005; Zhang et al., 2008). The second UBA in theStructure 20,UBAP1 SOUBA lacks the signature motif, and instead, it has
a KGF sequence in the analogous position. Nevertheless,
CSP mapping suggests that this KGF motif is also involved in
ubiquitin binding, because it has the highest CSP of all residues
upon ubiquitin binding. In addition to residues in these signature
motifs, other residues along the same face of the SOUBA also
show CSPs that are greater than 0.2 ppm. For UBA1 and
UBA2, almost all of these residues are at the end of the first
helix and on one face of the third helix within the UBAs.
Although the ‘‘di-leucine’’ motif in the third helix of UBA
domains is a second general signature motif, the equivalent
residues in SOUBA (residues 427-LF in UBA1, 461-LQ in
UBA2, and 495-LM in UBA3) do not show large CSPs on ubiq-
uitin binding. The leucine in each of these motifs is involved in
helical packing in the hydrophobic core. The largest CSPs
that we observe in UBA1 and UBA2 are consistent with interac-
tions that are typical of previously characterized UBA/monoubi-
quitin-interacting surfaces. However, the SOUBA UBA3 has a
broader distribution of residues with large CSPs on all three
of its helices, including a region that has been referred to as
the ‘‘backside’’ of the third UBA helix. This could be due to
conformational changes in the third UBA on ubiquitin binding,
or due to an additional ubiquitin-binding site.
Paramagnetic relaxation enhancement (PRE) measurements
were performed to probe directly the binding of each of the
three UBA domains in SOUBA to ubiquitin and to investigate
the relative orientation of SOUBA and monoubiquitin in the
complex. A paramagnetic spin label (SL) was attached to
a cysteine residue replacing a lysine in ubiquitin, in order to
induce a strong signal attenuation in nuclei that are near the
SL. Figure 7 depicts signal attenuations in the SOUBA in
a complex with ubiquitin spin-labeled at either residue 6
(K6C mutant, Figures 7G and 7H) or residue 48 (K48C mutant,
Figures 7I and 7J), compared to the same complexes in which
the SL probe is inactivated by ascorbic acid. The results clearly
show three regions of significant attenuation for K6C-SL
ubiquitin (corresponding to the end of helix 1 and the
loop between helix 1 and helix 2; the end of helix 3 and the
loop between helix 3 and helix 4; the end of helix 5 and
the loop between helix 5 and helix 6). Four regions of attenua-
tion were observed on SOUBA with the K48C-SL ubiquitin (the
loop between helix 1 and helix 2; the end of helix 3 and the
loop between helix 3 and helix 4; the end of helix 5 and
the loop between helix 5 and helix 6; and the end of helix 7).
The additional signal attenuation observed for K48C-SL would
suggest that the spin-label in K48C ubiquitin is close in space
to two regions of each UBA motif. No paramagnetic effects
were observed with D39C and S57C spin-labeled monoubiqui-
tins. A model of the SOUBA bound to three monoubiquitin
molecules reveals how the SL could achieve the effects
observed (Figures 7H and 7J). The PRE measurements appear
to match those observed by Zhang et al. (2008) when SL were
used to investigate binding of the UBA domain of ubiquilin-1
with monoubiquitin. It is worth noting that the attachment of
the SL to the mutant ubiquitins did not affect their ability to
interact with SOUBA. Comparison of the NMR spectra of
15N-SOUBA in the presence of WT-Ub and SL-Ub (K6C,
K39C, K48C, and K57C) revealed that the same CSP and
relaxation regimes were observed.414–428, March 7, 2012 ª2012 Elsevier Ltd All rights reserved 419
Figure 3. UBAP1 Depletion Prevents K5-Mediated Tetherin Degradation
(A) Western blots of cell lysates from HT1080 cells stably expressing HA-tetherin alone (HT1080:HA-THN) or in combination with K5 (HT1080:HA-THN/K5) and
treated with siRNAs against an irrelevant control (cont), TSG101 or UBAP1. THN-HA was detected with anti-HA antibody, with tubulin as a loading control and
visualized using Li-Cor fluorescently coupled 650 and 800 nm secondary antibodies. The graphs show the percentage of mature tetherin levels, normalized to
Structure
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Figure 4. Role of UBAP1 in ESCRT-I Medi-
ated HIV-1 Release and Cytokinesis
(A) Infectious virus release upon coexpression of
an HIV-1 provirus with an irrelevant siRNA (Cont),
siRNA against TSG101 or two different siRNAs
against UBAP1. Western blots show intracellular
TSG101, UBAP1, and HSP90 (protein loading
control) as well as intracellular (cell lysates) and
virion-associated (virions) HIV Gag protein.
(B) Quantification of cells with multiple nuclei after
treatment with the irrelevant control siRNA (Cont),
siRNA against hIST1 (positive control), or with
either of the two different siRNAs against UBAP1.
As for (A), western blots show siRNA-mediated
silencing of the endogenous hIST1 and UBAP1
and HSP90 as a protein loading control. Error bars
indicate the standard deviation from the mean of
three independent experiments.
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The results presented in this study demonstrate that recombi-
nant UBAP1 assembles with TSG101, VPS28, and VPS37 into
a complex with a 1:1:1:1 stoichiometry and, importantly, this
interaction is also observed in vivo with endogenous UBAP1
and physiological levels of the remaining ESCRT-I subunits.
Codepletion of TSG101 and UBAP1 in cells treated with
siRNA against TSG101 suggests that endogenous UBAP1 is
stabilized by its interaction with TSG101. Moreover, UBAP1’s
ability to functionally recruit the ESCRT machinery in
a TSG101-dependent manner provides further evidence for
a functional link between UBAP1 and ESCRT-I. On the basis
of these observations, we propose that UBAP1 is a stable
subunit of human ESCRT-I. While this manuscript was in
preparation, Woodman and colleagues have reported findingstubulin loading. Error bars indicate the standard deviation from themean of three independent experiments. Lo
and tubulin as a loading control.
(B) Confocal immunofluorescence showing localization of tetherin, CD63, and ubiquitin in cells treated with e
siRNA. A higher magnification of the boxed areas is shown in TSG101- and UBAP1-treated panels. In the ove
and CD63 or ubiquitin in red. See also Table S3.
Structure 20, 414–428, March 7, 2012that are entirely consistent with our
results (Stefani et al., 2011).
In a recombinant system, UBAP1 can
form heterotetrameric complexes with
TSG101, VPS28, and each of the four
VPS37 subunits. Our results also show
that transiently transfected VPS37A and
VPS37B form UBAP1-containing
complexes in 293T cells. Similarly,
a recent study of UBAP1 expressed in
HeLa cells showed complex formation
with VPS37A. However, the same study
did not detect formation of UBAP1
complexes with VPS37C (Stefani et al.,
2011). This could mean that additional
factors such as posttranslational modifi-
cations could modulate the association
between UBAP1 and VPS37 subunits incells. Little is known about the tissue distribution and cellular
abundance of different VPS37 subunits or competing MVB12A
and MVB12B, all of which could affect association with UBAP1.
UBAP1’s function is exclusively required for degradation of
ubiquitinated endosomal cargo but not for other ESCRT-I-medi-
ated processes such as midbody abscission or viral budding.
More specifically, we show that UBAP1-containing ESCRT-I
complexes are parasitized by viral immunomodulatory proteins
that target host membrane proteins for endosomal degradation,
in particular the targeted destruction of the antiviral protein
tetherin by both HIV-1 Vpu and KSHV K5 ubiquitin ligase. The
essential role of UBAP1 in K5 function is entirely consistent
with previous findings showing the ESCRT-dependent destruc-
tion of tetherin via a single lysine in its cytoplasmic tail (Mansouri
et al., 2009; Pardieu et al., 2010). In contrast, the pathway
involved in tetherin degradation and antagonism by Vpu haswer panels show depletion of TSG101 andUBAP1,
ither control siRNA-, TSG101-, or UBAP1-specific
rlay panels, DNA is shown in blue, tetherin in green,
ª2012 Elsevier Ltd All rights reserved 421
Figure 5. Ubiquitin Binding to UBAP1
Binding of human UBAP1 SOUBA domain (389–502) or UBAP1-containing ESCRT-I complex consisting of full-length UBAP1, VPS28 (full-length), TSG101 (198–
390, i.e., lacking the UEV domain) and VPS37A (229–397, i.e., lacking the UEV domain). The experimental data (squares) were fit using a bindingmodel for a single
set of independent sites. The mean Kd and standard deviation were calculated from three independent measurements.
(A) ITC titration of monoubiquitin into a cell containing the UBAP1 SOUBA domain (389–502), with the thermogram shown on top and integrated peaks shown on
bottom.
(B) ITC titration of monoubiquitin into a cell containing ESCRT-I with full-length UBAP1: thermogram (top) and integrated peaks (bottom).
(C) ITC titration of the SOUBA domain into a cell containing K63 diubiquitin: thermogram (top) and integrated peaks (bottom).
(D) ITC titration of the SOUBA domain into a cell containing K48 diubiquitin: thermogram (top) and integrated peaks (bottom).
Structure
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Figure 6. Overlapping UBAs Build a Compact SOUBA Domain
(A) Overview of UBAP1 SOUBA domain (389–502), showing the tandem arrangement of the three overlapping UBA domains rainbow colored from N terminus
(blue) to C terminus (red).
(B) Sequence alignment of each of the threeUBAdomains of UBAP1with three other well-characterizedUBAdomains. UBA signaturemotif residues are shown in
red and represented as sticks in (A). Residues mutated in the SOUBA crystal structure are shown with a blue background.
(C) Structural alignment of each of the three UBAP1 UBA domains with the three previously reported UBA domains present in the sequence alignment (B), namely
Ubiquilin1 (2JY5) in light gray, DSK2 UBA (2BWB) in medium gray, and HHR23A UBA2 (1DV0) in dark gray. See also Table 1.
Structure
UBAP1 Is Required for Tetherin Degradationbeen less clear (Martin-Serrano and Neil, 2011). Although early
studies suggested that Vpu induced proteasomal degradation
of tetherin (Goffinet et al., 2009), more recent reports show
that, in HIV-1-infected cells, tetherin is targeted to lysosomes
(Douglas et al., 2009; Iwabu et al., 2009; Mitchell et al., 2009)
and its inactivation is dependent on an association with Hrs
(ESCRT-0) (Janvier et al., 2011). Our demonstration that
UBAP1 is essential for Vpu-induced tetherin destruction shows
that tetherin is degraded in the MVB pathway rather than by
the proteasome. However, it is also clear that tetherin degrada-
tion is not a prerequisite for Vpu activity. Even though tetherin is
not degraded in UBAP1-depleted cells and accumulates in
endosomes, Vpu is still able to efficiently counteract tetherin’s
antiviral activity.
A Model of Ubiquitin Binding to the SOUBA
At a mechanistic level, we demonstrate the ability of UBAP1 to
promote the interaction of ESCRT-I with ubiquitin. A UBAP1-
containing ESCRT-I complex is able to bind ubiquitin via the
SOUBA domain located in the C-terminal region of UBAP1.
The importance of this interaction is suggested by a reported
frameshift mutation that precisely removes the SOUBA domainStructure 20,(S391Afs21X) in one case of familial frontotemporal lobar degen-
eration (Rollinson et al., 2009). Accordingly, mutations in the
SOUBA domain disrupt sorting of endosomal cargo (Stefani
et al., 2011). To our knowledge, the structure of this region shows
a novel ubiquitin-binding fold, the SOUBA domain. The ability
of UBAP1 to bind monoubiquitin may be important for the
function of the ESCRT-I pathway, because half of conjugated
ubiquitin is in the form of monoubiquitin or endcaps of polyubi-
quitin chains (Ziv et al., 2011), and monoubiquitination is a suffi-
cient signal for vacuolar/lysosomal traffic (Stringer and Piper,
2011).
By superimposing the SOUBA domain on different UBAs
whose structures have been solved in complexes with monou-
biquitin, it is possible to generate a model of the SOUBA
bound to ubiquitin. In this model, SOUBA can easily accommo-
date three monoubiquitins adjacent to each other, on the
convex face of the domain (Figure 8). Each of the three UBAs
engages with the hydrophobic patch of ubiquitin that includes
Ile44 and Val70. Both the CSPs observed for 15N-labeled ubiqui-
tin upon addition of an excess of unlabelled SOUBA (Figure 7C)
and the relaxation induced by a paramagnetic probe attached
to ubiquitin in complex with the SOUBA (Figures 7G–7J), are414–428, March 7, 2012 ª2012 Elsevier Ltd All rights reserved 423
Figure 7. UBAP1 Interactions with Monoubiquitin Detected by NMR Chemical Shift Perturbations
(A) Overlay of HSQC spectra of 15N-labeledmonoubiquitin in the absence (black) and presence (red) of 2.5molar equivalents of unlabeled UBAP1 SOUBA. Amide
resonances with significant chemical shift changes have been annotated.
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Figure 8. Model of Monoubiquitin Binding
to the UBAP1 SOUBA
The UBA1, UBA2, and UBA3 are colored blue,
yellow, and red, respectively. UBAP1 residues
showing a CSP >0.2 ppm upon binding to mono-
ubiquitin are shown as green sticks. Three mon-
oubiquitins have been docked on the basis of
superposition of each UBA domain with the ubiq-
uilin UBA domain in complex with ubiquitin (PDB
ID 2JY6). Ubiquitin residues with CSPs >0.2 ppm
upon binding to the UBAP1 SOUBA are shown as
magenta sticks. The PRE and CSPmeasurements
show that all three UBAs bind ubiquitin. The
gradual addition of substoichiometric amounts of
ubiquitin causes chemical shifts for residues in all
three UBA motifs, suggesting that there is no
preference for the binding of ubiquitin to one site
versus another. The NMR data indicated that
binding occurs at each of the sites, but cannot
distinguish whether one, two, or three molecules
are bound at the same time. Nevertheless, there
appear to be no steric clashes in the model that
would prevent all three ubiquitins binding simul-
taneously.
Structure
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orientations of the ubiquitins would not appear to allow the ubiq-
uitins occupying adjacent sites on the SOUBA to be linked to
each other either through K48 or K63 isopeptide bonds. This is
consistent with our ITC results suggesting that these linkages
bind no better than monoubiquitin to the SOUBA (Figure 5).
Previous NMR studies of UBAs from several different proteins
in the presence of K48-linked diubiquitin suggest a second
binding site for the secondubiquitin involving a separate interface
on the UBA (Sims et al., 2009; Song et al., 2009; Trempe et al.,
2005; Varadan et al., 2005). The solenoid arrangement of the
SOUBA would appear to block this type of binding, at least for
the first two UBAs.
The NMR data demonstrate that each of the three UBAs
is involved in ubiquitin binding, but it remains to be shown
whether all three UBAs can bind ubiquitin simultaneously. We
tried investigating the affinity of each UBA for ubiquitin by
generating double point mutants in the (M/K)G(F/Y) motifs: we
constructed three mutant SOUBAs, each having only one func-
tional UBA. However, NMR HSQC spectra revealed that each of
these mutants was unstructured, preventing further study.
ITC results for the full-length UBAP1 in the ESCRT-I complex
show a lower affinity for monoubiquitin than the isolated
SOUBA domain. This might suggest a more restricted access
to the SOUBA in the ESCRT-I complex. Because of the difficul-(B) Plot of chemical shift perturbations (CSPs) for 15N-labeled monoubiquitin as a
have been assigned a value of 0 ppm and are marked by an asterisk.
(C) CSPs for monoubiquitin mapped onto its structure.
(D) Overlay of HSQC spectra of 15N-labeled SOUBA in the absence (black) and p
(E) Plot of CSPs for 15N-labeled SOUBA as a function of residue number.
(F) CSPs for SOUBA mapped onto its structure.
(G–J) Paramagnetic relaxation enhancement effects in the SOUBA/Ub complex in
The graphs plot experimental PREs observed in SOUBA upon addition of the SL-u
in green on a model of SOUBA bound to three molecules of ubiquitin for K6C-SL
labeling) are shown as salmon sticks.
Structure 20,ties associated with producing sufficient quantities of diubiqui-
tin, it was not possible to determine the affinity of UBAP1-
containing ESCRT-I for K63-linked and K48-linked diubiquitin
by ITC.
Because the shape of the SOUBA domain and the interaction
sites mapped by NMR lead to a model in which three bound
ubiquitins are aligned and close enough to be attached via
some other type of linkage than K48 or K63, it will be exciting
to examine UBAP1 affinities for other polyubiquitin linkages.
Alternatively, in addition to providing a grip on monoubiquiti-
nated cargo, the SOUBA domain could enable avid interaction
with multiply monoubiquitinated cargoes, or monoubiquitinated
clustered cargoes. All of these are frequent passengers in the
ESCRT-dependent sorting to MVBs.
EXPERIMENTAL PROCEDURES
Plasmid Construction
Human UBAP1 was amplified by PCR from IMAGE clone 40011243. All dele-
tions and point mutant derivatives were generated by PCR in a similar way. All
of the constructs used in the study are listed in Table S1.
Expression and Purification of Recombinant ESCRT-I Proteins
Genes coding for human VPS28 (full length or 1-122), TSG101 (198-390),
VPS37A (229-397), andUBAP1 (full length or deletion variantswith aC-terminal
His6-tag) were cloned in a polycistronic coexpression vector as describedfunction of residue number. Proline residues (for which no data are available)
resence (red) of three molar equivalents of unlabeled monoubiquitin.
duced by the spin label attached to the K6C (G) and K48C (I) mutant ubiquitins.
biquitin against residue number. Significant paramagnetic effects are illustrated
(H) and K48C-SL (J). The side chains of K6 and K48 (mutated to a Cys for spin
414–428, March 7, 2012 ª2012 Elsevier Ltd All rights reserved 425
Table 1. Crystallographic Statistics
Se-Met Crystal For Structure Refinement
Structure
UBAP1 Is Required for Tetherin Degradationelsewhere (Teo et al., 2006). The constructs expressed are listed in Table S1.




a, b, c (A˚) 34.40, 43.48, 59.41
a, b, g () 102.57, 96.47, 113.24
Wavelength 0.98Expression and Purification of SOUBA
Human SOUBA domain (UBAP1 389-502) either wild-type or containing the
K415A, K416A, and E418A triple mutation was cloned in the pOPTH(tev)
expression vector downstream of an N-terminal His6-tag followed by a TEV
protease cleavage site. The expression and purification were performed as
described in Supplemental Experimental Procedures.Resolution (A˚) 38.3 (1.65)a
Rsym or Rmerge 0.055 (0.54)
I / sI 9.9 (1.9)
Completeness (%) 95.9 (94.4)
Redundancy 3.9 (3.9)
RefinementCrystallization, Data Collection, and Refinement of SOUBA
Seleno-methionine crystals of the human SOUBA domain (UBAP1 389-502)
with the K415A, K416A, and E418A triple mutation designed to reduce surface
enthropy charge (using SERp server: http://services.mbi.ucla.edu/SER/)
were used for crystallization (see Supplemental Experimental Procedures
and Table 1).Resolution (A˚) 1.65
No. reflections 36253








Water 47Isothermal Titration Calorimetry
Assays were performed using a Microcal ITC200, in 20 mM Tris-HCl (pH 7.5),
100 mM NaCl, and 1 mM TCEP. The ITC cell contained either the SOUBA
domain (UBAP1(389-502)) at 150 mM or full-length UBAP1 associated with
VPS28 (full-length), TSG101 (198-390, i.e., lacking the UEV domain), and
VPS37A (229-397, i.e., lacking the UEV domain), at 75 mM and was titrated
with 38 injections of monoubiquitin (SIGMA U6253) at 3 mM. Assays on
K63-linked and K48-linked diubiquitins were performed having diubiquitin in
the cell at 100 mM, titrated by 38 injections of the SOUBA domain at
2.3 mM. Data were fit with a binding model employing a single set of indepen-
dent sites.
Expression and purification of paramagnetically labeled monoubiquitin was
performed as described in Supplemental Experimental Procedures.R.m.s deviations
Bond lengths (A˚) 0.0165
Bond angles () 1.536
aThe values in parentheses are for the highest resolution shell, 1.74 A˚ to
1.65 A˚.NMR Spectroscopy
Wild-type SOUBA (UBAP1_389-502) samples prepared for NMR spectros-
copy experiments were typically 1.0 mM in 90% H2O and 10% D2O in PBS
with 10 mM DTT. All spectra were acquired with either a Bruker Advance
700 or a DRX600 spectrometer at 20C, and referenced relative to external
sodium 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) for proton and carbon
signals, or liquid ammonium for nitrogen. Assignments were obtained using
standard NMRmethods with 13C/15N-labeled and 15N-labeled samples. Back-
bone assignments were obtained using the following standard set of 2D and
3D heteronuclear spectra: 1H-15N HSQC, HNCACB, CBCA(CO)NH, HACACO,
HNCO, CCCONH, and 1H-13C HSQC. HSQC titrations were performed using
0.5 mM 15N-labeled UBAP1 and varying concentrations of unlabeled ubiquitin.
Similar titrations were performed with 0.3 mM 15N-labeled ubiquitin and unla-









where DdH and DdN are the observed chemical shift changes for
1H and 15N,
respectively. Paramagnetic experiments were performed using sample con-
taining 0.3 mM SOUBA and 0.3 mM chemically modified monoubiquitin.Generation of Stable Cell Lines
HT1080/THN-HA K5 cells have been described elsewhere (Pardieu et al.,
2010). To generate HeLa OSHA-TSG101, 293T cells were transfected with
100 ng of pHIT-VSVG, 700 ng of MLV-GagPol, and 200 ng of the pCMS28
retroviral packaging vector for 48 hr. Viral-containing supernatants were
collected and used to transduce HeLa. Selection with puromycin (200 ng/ml)
was applied 48 hr later, and cells were passaged under continual selection.Coprecipitation Assays
These were performed as described in Supplemental Experimental
Procedures.426 Structure 20, 414–428, March 7, 2012 ª2012 Elsevier Ltd All righHIV Infectivity Assays
Cells (293T) were transfected with 250 ng of the YFP fusions and 300 ng of
pNL/HXB using polyethylenimine. Culture supernatants, collected 48 hr after
transfection, were clarified by low-speed centrifugation, and particles present
in 250 ml were obtained by centrifugation through a 20% sucrose cushion at
14,000 rpm for 2 hr. Viral protein content in cell and particle lysates was
analyzed bywestern blotting with an anti-Gag antibody. Alternatively, indicator
HeLa-TZM-bl cells (CD4+, CXCR4+, CCR5+, HIV-1 LTR- LacZ) (Derdeyn et al.,
2000) were infected with 1 ml of supernatant and 48 hr later, b-galactosidase
activities in cell lysates were measured using the chemiluminescent detection
reagent Galacto-Star (Applied Biosystems).
To assay inhibition of viral production by siRNA-mediated depletion of
cellular UBAP1, 293T cells were initially transfected with 50 pmol of siRNA
using Dharmafect1 (Dharmacon) and were split the next day. Forty-eight hours
after initial transfection, cells were cotransfected with 50 pmol of siRNA and
the HIV proviral plasmid using lipofectamine 2000 (Invitrogen). The detailed
sequence of the siRNA oligos used is provided in Table S2. The plasmids
and method for the trans-complementation assay have been described previ-
ously (Martin-Serrano et al., 2001).
Multinucleation Assays
The multinucleation assays for HeLa cells were performed as described in
Supplemental Experimental Procedures.
Vpu-Mediated Tetherin Degradation Assay
Subconfluent 293T cells stably expressing tetherin were seeded in a six-well
plate and 2 hr after plating were transfected with 50 pmol of siRNA usingts reserved
Structure
UBAP1 Is Required for Tetherin DegradationDharmafect-1 (Dharmacon). Forty-eight hours later, cells were reseeded and
transfected again with 50 pmol of siRNA. Six hours after the second RNAi
transfection, cells were infected with HIV-1 wild-type or Vpu-deficient at an
MOI of 2. At 48 hr after infection, the cells were lysed on ice for 30 min in buffer
containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, complete protease inhib-
itors (Roche), and 1% digitonin (Calbiochem). After removal of the nuclei, the
resulting supernatants were incubated with 1 mg/ml mouse anti-tetherin
(eBiosciences) for 2 hr at 4C before addition of 40 ml of protein G-agarose
(Invitrogen) for a further 3 hr. The beads were then washed four times in lysis
buffer containing 0.1% digitonin. After the final wash, beads were resus-
pended in water and treated with the protein deglycosylation kit from New
England Biolabs under denaturing conditions as specified by the supplier.
Samples were resuspended in SDS-PAGE loading buffer and cell lysates
and immunoprecipitates were then western blotted for tetherin using rabbit
anti-BST2 (kindly provided by K. Strebel through the NIH ARRP).K5-Mediated Tetherin Degradation Assay
Total tetherin-HA levels were analyzed by western blot of cell lysates after
siRNA treatment of HT1080 cells stably expressing HA-tetherin alone
(HT1080:HA-THN) or in combination with K5 (HT1080:HA-THN/K5). Tetherin-
HA was detected with anti-HA antibody, with tubulin as a loading control,
and visualized using Li-Cor fluorescently coupled 650 and 800 nm secondary
antibodies.Western Blot Analysis
Cell extracts, as well as virion lysates, were separated on 10% or 12% poly-
acrylamide gels and transferred to nitrocellulose membranes. A list of anti-
bodies used is provided in Table S3.Immunofluorescence Microscopy
HT1080:HA-THN and HT1080:HA-THN/K5 cells were treated with siRNA as
described above for the multinucleation assays. At 24 hr after transfection,
the cells were fixed in 4% paraformaldehyde, permeabilized in 0.1% Triton
X-100, and immunostained using a rabbit anti-HA antibody (Rockland) and
mouse anti-CD63 (Developmental studies Hybridoma Bank. University of
Iowa) or mouse anti-Mono and polyubiquitylated conjugates (clone FK2)
(Enzo Life Sciences) followed by the appropriate donkey secondary antibodies
coupled to Alexa 488 and 594 fluorophores (Invitrogen). Nuclei were visualized
using Hoechst 33258 and coverslips were mounted in Mowiol. Images were
taken using a Leica AOBS SP2 confocal microscope.SUPPLEMENTAL INFORMATION
Supplemental Information includes one figure, three tables, and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
1016/j.str.2011.12.013.ACKNOWLEDGMENTS
J.M.S. is funded by the Lister Institute, the EMBO Young Investigator Pro-
gramme, and the Medical Research Council (grant G0802777). J.M.S. and
M.A. are funded by theWellcome Trust (grant WT093056MA). R.L.W. is funded
by the Wellcome Trust (grant 083639/Z/07/Z) and the Medical Research
Council (file referenceU105184308). We thankMichael Hadders for comments
on the manuscript, Chris Johnson for help with ITC, and Stephen McLaughlin
for help with Octet measurements. We thank David Cobessi and Elspeth Gor-
don for help with data collection at ESRF beamlines BM30A and ID23-1,
respectively.
Received: August 22, 2011
Revised: December 13, 2011
Accepted: December 30, 2011
Published: March 6, 2012Structure 20,REFERENCES
Agromayor, M., Carlton, J.G., Phelan, J.P., Matthews, D.R., Carlin, L.M.,
Ameer-Beg, S., Bowers, K., and Martin-Serrano, J. (2009). Essential role of
hIST1 in cytokinesis. Mol. Biol. Cell 20, 1374–1387.
Bache, K.G., Slagsvold, T., Cabezas, A., Rosendal, K.R., Raiborg, C., and
Stenmark, H. (2004). The growth-regulatory protein HCRP1/hVps37A is
a subunit of mammalian ESCRT-I and mediates receptor down-regulation.
Mol. Biol. Cell 15, 4337–4346.
Bajorek, M., Morita, E., Skalicky, J.J., Morham, S.G., Babst, M., and
Sundquist, W.I. (2009). Biochemical analyses of human IST1 and its function
in cytokinesis. Mol. Biol. Cell 20, 1360–1373.
Bartee, E., McCormack, A., and Fru¨h, K. (2006). Quantitative membrane pro-
teomics reveals new cellular targets of viral immune modulators. PLoS
Pathog. 2, e107.
Baumga¨rtel, V., Ivanchenko, S., Dupont, A., Sergeev, M., Wiseman, P.W.,
Kra¨usslich, H.G., Bra¨uchle, C., Mu¨ller, B., and Lamb, D.C. (2011). Live-cell
visualization of dynamics of HIV budding site interactions with an ESCRT
component. Nat. Cell Biol. 13, 469–474.
Bucher, P., Karplus, K., Moeri, N., and Hofmann, K. (1996). A flexible motif
search technique based on generalized profiles. Comput. Chem. 20, 3–23.
Carlton, J.G., andMartin-Serrano, J. (2007). Parallels between cytokinesis and
retroviral budding: a role for the ESCRT machinery. Science 316, 1908–1912.
Clague, M.J., and Urbe´, S. (2010). Ubiquitin: same molecule, different degra-
dation pathways. Cell 143, 682–685.
de Souza, R.F., and Aravind, L. (2010). UMA andMABP domains throw light on
receptor endocytosis and selection of endosomal cargoes. Bioinformatics 26,
1477–1480.
Derdeyn, C.A., Decker, J.M., Sfakianos, J.N., Wu, X., O’Brien, W.A., Ratner, L.,
Kappes, J.C., Shaw, G.M., and Hunter, E. (2000). Sensitivity of human immu-
nodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by corecep-
tor specificity defined by the V3 loop of gp120. J. Virol. 74, 8358–8367.
Derewenda, Z.S. (2011). It’s all in the crystals.. Acta Crystallogr. D Biol.
Crystallogr. 67, 243–248.
Dikic, I., Wakatsuki, S., and Walters, K.J. (2009). Ubiquitin-binding domains—
from structures to functions. Nat. Rev. Mol. Cell Biol. 10, 659–671.
Douglas, J.L., Viswanathan, K., McCarroll, M.N., Gustin, J.K., Fru¨h, K., and
Moses, A.V. (2009). Vpu directs the degradation of the human immunodefi-
ciency virus restriction factor BST-2/Tetherin via a betaTrCP-dependent
mechanism. J. Virol. 83, 7931–7947.
Eastman, S.W., Martin-Serrano, J., Chung, W., Zang, T., and Bieniasz, P.D.
(2005). Identification of human VPS37C, a component of endosomal sorting
complex required for transport-I important for viral budding. J. Biol. Chem.
280, 628–636.
Goffinet, C., Allespach, I., Homann, S., Tervo, H.M., Habermann, A., Rupp, D.,
Oberbremer, L., Kern, C., Tibroni, N., Welsch, S., et al. (2009). HIV-1 antago-
nism of CD317 is species specific and involves Vpu-mediated proteasomal
degradation of the restriction factor. Cell Host Microbe 5, 285–297.
Goldschmidt, L., Cooper, D.R., Derewenda, Z.S., and Eisenberg, D. (2007).
Toward rational protein crystallization: aWeb server for the design of crystalliz-
able protein variants. Protein Sci. 16, 1569–1576.
Henne, W.M., Buchkovich, N.J., and Emr, S.D. (2011). The ESCRT pathway.
Dev. Cell 21, 77–91.
Hofmann, K., and Bucher, P. (1996). The UBA domain: a sequence motif
present in multiple enzyme classes of the ubiquitination pathway. Trends
Biochem. Sci. 21, 172–173.
Hurley, J.H., and Stenmark, H. (2011). Molecular mechanisms of ubiquitin-
dependent membrane traffic. Annu. Rev. Biophys. 40, 119–142.
Iwabu, Y., Fujita, H., Kinomoto, M., Kaneko, K., Ishizaka, Y., Tanaka, Y., Sata,
T., and Tokunaga, K. (2009). HIV-1 accessory protein Vpu internalizes cell-
surface BST-2/tetherin through transmembrane interactions leading to lyso-
somes. J. Biol. Chem. 284, 35060–35072.
Janvier, K., Pelchen-Matthews, A., Renaud, J.B., Caillet, M., Marsh, M., and
Berlioz-Torrent, C. (2011). The ESCRT-0 component HRS is required for414–428, March 7, 2012 ª2012 Elsevier Ltd All rights reserved 427
Structure
UBAP1 Is Required for Tetherin DegradationHIV-1 Vpu-mediated BST-2/tetherin down-regulation. PLoS Pathog. 7,
e1001265.
Jouvenet, N., Zhadina, M., Bieniasz, P.D., and Simon, S.M. (2011). Dynamics
of ESCRT protein recruitment during retroviral assembly. Nat. Cell Biol. 13,
394–401.
Katzmann, D.J., Babst, M., and Emr, S.D. (2001). Ubiquitin-dependent sorting
into the multivesicular body pathway requires the function of a conserved en-
dosomal protein sorting complex, ESCRT-I. Cell 106, 145–155.
Kostelansky, M.S., Sun, J., Lee, S., Kim, J., Ghirlando, R., Hierro, A., Emr, S.D.,
and Hurley, J.H. (2006). Structural and functional organization of the ESCRT-I
trafficking complex. Cell 125, 113–126.
Kostelansky, M.S., Schluter, C., Tam, Y.Y., Lee, S., Ghirlando, R., Beach, B.,
Conibear, E., and Hurley, J.H. (2007). Molecular architecture and functional
model of the complete yeast ESCRT-I heterotetramer. Cell 129, 485–498.
Long, J., Gallagher, T.R., Cavey, J.R., Sheppard, P.W., Ralston, S.H., Layfield,
R., and Searle, M.S. (2008). Ubiquitin recognition by the ubiquitin-associated
domain of p62 involves a novel conformational switch. J. Biol. Chem. 283,
5427–5440.
Mansouri, M., Viswanathan, K., Douglas, J.L., Hines, J., Gustin, J., Moses,
A.V., and Fru¨h, K. (2009). Molecular mechanism of BST2/tetherin downregula-
tion by K5/MIR2 of Kaposi’s sarcoma-associated herpesvirus. J. Virol. 83,
9672–9681.
Martin-Serrano, J., and Neil, S.J. (2011). Host factors involved in retroviral
budding and release. Nat. Rev. Microbiol. 9, 519–531.
Martin-Serrano, J., Zang, T., and Bieniasz, P.D. (2001). HIV-1 and Ebola virus
encode small peptidemotifs that recruit Tsg101 to sites of particle assembly to
facilitate egress. Nat. Med. 7, 1313–1319.
Martin-Serrano, J., Zang, T., and Bieniasz, P.D. (2003). Role of ESCRT-I in
retroviral budding. J. Virol. 77, 4794–4804.
McDonald, B., andMartin-Serrano, J. (2008). Regulation of Tsg101 expression
by the steadiness box: a role of Tsg101-associated ligase. Mol. Biol. Cell 19,
754–763.
Mitchell, R.S., Katsura, C., Skasko, M.A., Fitzpatrick, K., Lau, D., Ruiz, A.,
Stephens, E.B., Margottin-Goguet, F., Benarous, R., and Guatelli, J.C.
(2009). Vpu antagonizes BST-2-mediated restriction of HIV-1 release via
beta-TrCP and endo-lysosomal trafficking. PLoS Pathog. 5, e1000450.
Morita, E., and Sundquist, W.I. (2004). Retrovirus budding. Annu. Rev. Cell
Dev. Biol. 20, 395–425.
Morita, E., Sandrin, V., Alam, S.L., Eckert, D.M., Gygi, S.P., and Sundquist,W.I.
(2007a). Identification of human MVB12 proteins as ESCRT-I subunits that
function in HIV budding. Cell Host Microbe 2, 41–53.
Morita, E., Sandrin, V., Chung, H.Y., Morham, S.G., Gygi, S.P., Rodesch, C.K.,
and Sundquist, W.I. (2007b). Human ESCRT and ALIX proteins interact with
proteins of the midbody and function in cytokinesis. EMBO J. 26, 4215–4227.
Morita, E., Sandrin, V., McCullough, J., Katsuyama, A., Baci Hamilton, I., and
Sundquist, W.I. (2011). ESCRT-III protein requirements for HIV-1 budding. Cell
Host Microbe 9, 235–242.
Mueller, T.D., and Feigon, J. (2002). Solution structures of UBA domains reveal
a conserved hydrophobic surface for protein-protein interactions. J. Mol. Biol.
319, 1243–1255.
Nathan, J.A., and Lehner, P.J. (2009). The trafficking and regulation of
membrane receptors by the RING-CH ubiquitin E3 ligases. Exp. Cell Res.
315, 1593–1600.
Neil, S.J., Zang, T., and Bieniasz, P.D. (2008). Tetherin inhibits retrovirus
release and is antagonized by HIV-1 Vpu. Nature 451, 425–430.
Ohno, A., Jee, J., Fujiwara, K., Tenno, T., Goda, N., Tochio, H., Kobayashi, H.,
Hiroaki, H., and Shirakawa, M. (2005). Structure of the UBA domain of Dsk2p in
complex with ubiquitin molecular determinants for ubiquitin recognition.
Structure 13, 521–532.
Pardieu, C., Vigan, R., Wilson, S.J., Calvi, A., Zang, T., Bieniasz, P., Kellam, P.,
Towers, G.J., and Neil, S.J. (2010). The RING-CH ligase K5 antagonizes428 Structure 20, 414–428, March 7, 2012 ª2012 Elsevier Ltd All righrestriction of KSHV and HIV-1 particle release by mediating ubiquitin-depen-
dent endosomal degradation of tetherin. PLoS Pathog. 6, e1000843.
Pohl, C. (2009). Dual control of cytokinesis by the ubiquitin and autophagy
pathways. Autophagy 5, 561–562.
Pornillos, O., Alam, S.L., Davis, D.R., and Sundquist, W.I. (2002). Structure of
the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6
protein. Nat. Struct. Biol. 9, 812–817.
Qian, J., Yang, J., Zhang, X., Zhang, B., Wang, J., Zhou, M., Tang, K., Li, W.,
Zeng, Z., Zhao, X., Shen, S., et al. (2001). Isolation and characterization of
a novel cDNA, UBAP1, derived from the tumor suppressor locus in human
chromosome 9p21-22. J. Cancer Res. Clin. Oncol. 127, 613–618.
Raasi, S., Varadan, R., Fushman, D., and Pickart, C.M. (2005). Diverse poly-
ubiquitin interaction properties of ubiquitin-associated domains. Nat. Struct.
Mol. Biol. 12, 708–714.
Rollinson, S., Rizzu, P., Sikkink, S., Baker, M., Halliwell, N., Snowden, J.,
Traynor, B.J., Ruano, D., Cairns, N., Rohrer, J.D., et al. (2009). Ubiquitin asso-
ciated protein 1 is a risk factor for frontotemporal lobar degeneration.
Neurobiol. Aging 30, 656–665.
Shields, S.B., and Piper, R.C. (2011). How ubiquitin functions with ESCRTs.
Traffic 12, 1306–1317.
Shields, S.B., Oestreich, A.J., Winistorfer, S., Nguyen, D., Payne, J.A.,
Katzmann, D.J., and Piper, R. (2009). ESCRT ubiquitin-binding domains func-
tion cooperatively during MVB cargo sorting. J. Cell Biol. 185, 213–224.
Sims, J.J., Haririnia, A., Dickinson, B.C., Fushman, D., and Cohen, R.E. (2009).
Avid interactions underlie the Lys63-linked polyubiquitin binding specificities
observed for UBA domains. Nat. Struct. Mol. Biol. 16, 883–889.
Song, J., Park, J.K., Lee, J.J., Choi, Y.S., Ryu, K.S., Kim, J.H., Kim, E., Lee,
K.J., Jeon, Y.H., and Kim, E.E. (2009). Structure and interaction of ubiquitin-
associated domain of human Fas-associated factor 1. Protein Sci. 18, 2265–
2276.
Stefani, F., Zhang, L., Taylor, S., Donovan, J., Rollinson, S., Doyotte, A.,
Brownhill, K., Bennion, J., Pickering-Brown, S., and Woodman, P. (2011).
UBAP1 is a component of an endosome-specific ESCRT-I complex that is
essential for MVB sorting. Curr. Biol. 21, 1245–1250.
Stringer, D.K., and Piper, R.C. (2011). A single ubiquitin is sufficient for cargo
protein entry into MVBs in the absence of ESCRT ubiquitination. J. Cell Biol.
192, 229–242.
Stuchell, M.D., Garrus, J.E., Mu¨ller, B., Stray, K.M., Ghaffarian, S., McKinnon,
R., Kra¨usslich, H.G., Morham, S.G., and Sundquist,W.I. (2004). The human en-
dosomal sorting complex required for transport (ESCRT-I) and its role in HIV-1
budding. J. Biol. Chem. 279, 36059–36071.
Teo, H., Gill, D.J., Sun, J., Perisic, O., Veprintsev, D.B., Vallis, Y., Emr, S.D.,
and Williams, R.L. (2006). ESCRT-I core and ESCRT-II GLUE domain struc-
tures reveal role for GLUE in linking to ESCRT-I and membranes. Cell 125,
99–111.
Trempe, J.F., Brown, N.R., Lowe, E.D., Gordon, C., Campbell, I.D., Noble,
M.E., and Endicott, J.A. (2005). Mechanismof Lys48-linked polyubiquitin chain
recognition by the Mud1 UBA domain. EMBO J. 24, 3178–3189.
Varadan, R., Assfalg, M., Raasi, S., Pickart, C., and Fushman, D. (2005).
Structural determinants for selective recognition of a Lys48-linked polyubiqui-
tin chain by a UBA domain. Mol. Cell 18, 687–698.
Weissenhorn, W., and Go¨ttlinger, H. (2011). Essential ingredients for HIV-1
budding. Cell Host Microbe 9, 172–174.
Williams, R.L., and Urbe´, S. (2007). The emerging shape of the ESCRT
machinery. Nat. Rev. Mol. Cell Biol. 8, 355–368.
Zhang, D., Raasi, S., and Fushman, D. (2008). Affinity makes the difference:
nonselective interaction of the UBA domain of Ubiquilin-1 with monomeric
ubiquitin and polyubiquitin chains. J. Mol. Biol. 377, 162–180.
Ziv, I., Matiuhin, Y., Kirkpatrick, D.S., Erpapazoglou, Z., Leon, S.,
Pantazopoulou, M., Kim, W., Gygi, S.P., Haguenauer-Tsapis, R., Rein, N.,
et al. (2011). A perturbed ubiquitin landscape distinguishes between ubiquitin
in trafficking and in proteolysis. Mol. Cell Proteomics 10, M111.009753.ts reserved
